Navigation Links
MGuard(TM) Coronary Stent System Approved in Israel
Date:12/8/2008

TEL AVIV, Israel, December 8 /PRNewswire/ -- InspireMD, Ltd. announced that the MGuard(TM) coronary stent system has been approved for use in Israel by the Israeli Ministry of Health.

The MGuard(TM) stent system presents a novel combination of a coronary stent merged with an embolic protection device. Lifelong embolic protection is achieved by an expandable, flexible fishnet style, micron level knit sleeve that wraps the stent. In addition, MGuard(TM) blocks embolic showers and plaque detachment from the arterial wall, blocking debris at the source during and post procedure. The net is designed to diffuse stent pressure on the vessel wall, thereby reducing injury and lowering the likelihood of restenosis. Since MGuard(TM) received CE Mark approval in November 2007 the product has been met with much enthusiasm and celebrated by leading interventional cardiologists worldwide. "We are very excited about MGuard(TM) being approved for use in Israel so soon" stated Dr. Asher Holzer, InspireMD's President. "Our leading Israeli Interventional Cardiologists have been eager to have this life saving stent system available at their hospitals and already in the few days since the local approval, lives of Israelis have been saved with MGuard(TM)". MGuard's relatively early regulatory approval in Israel may have been partly due to numerous recommendations by local opinion leaders to the Ministry of Health.

InspireMD will celebrate the launch of MGuard(TM) in Israel at the upcoming ICI '08 Meeting in Tel-Aviv, December 8th-9th where MGuard(TM) will be demonstrated at booth #18. In addition, InspireMD will be hosting an inspiring cocktail reception symposium on December 8th at the ICI Meeting, MGuard(TM): A Unique Solution for Managing Embolic Complications in Acute MI and SVG. Martin Leon MD and Chaim Lotan MD will chair the meeting where additional speakers include key world renowned interventional cardiologists Martin Rothma
'/>"/>

SOURCE InspireMD, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
2. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
3. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
4. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
5. Surgery More Likely Than Angioplasty to Relieve Pain for Patients With Coronary Artery Disease
6. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
7. Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
8. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
9. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
10. CorNova Preclinical Results of Valecor Platinum(TM) Coronary Stent Studies Presented at TCT 2007 Conference
11. VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... , May 1, 2015  Misonix, Inc. (NASDAQ: ... that designs, manufactures and markets innovative therapeutic ultrasonic ... debridement, cosmetic surgery, laparoscopic surgery and other surgical ... results for the third quarter fiscal year 2015 ... scheduled a conference call that same day, Thursday, ...
(Date:5/1/2015)... NEW YORK , May 1, 2015  Shares ... over 70% of their value yesterday following the results ... company,s glaucoma therapy, Rhopressa.  Despite the trial failing to ... indicates that positive results may come from future studies. ... a brief company overview, current pipeline, financial review, analyst ...
(Date:4/30/2015)... 2015 Omnicell, Inc. (NASDAQ: OMCL ), a ... healthcare systems, today announced results for its first quarter ... for the first quarter of 2015 was $116.2 million, ... of 2014, and down $5.3 million or 4.4% from ... 2015 net income as reported in accordance with U.S. ...
Breaking Medicine Technology:Misonix, Inc. To Report Third Quarter Fiscal Year 2015 Financial Results On Thursday, May 7, 2015 2All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2Omnicell Announces First Quarter 2015 Results 2Omnicell Announces First Quarter 2015 Results 3Omnicell Announces First Quarter 2015 Results 4Omnicell Announces First Quarter 2015 Results 5Omnicell Announces First Quarter 2015 Results 6Omnicell Announces First Quarter 2015 Results 7Omnicell Announces First Quarter 2015 Results 8Omnicell Announces First Quarter 2015 Results 9Omnicell Announces First Quarter 2015 Results 10Omnicell Announces First Quarter 2015 Results 11Omnicell Announces First Quarter 2015 Results 12Omnicell Announces First Quarter 2015 Results 13Omnicell Announces First Quarter 2015 Results 14Omnicell Announces First Quarter 2015 Results 15Omnicell Announces First Quarter 2015 Results 16Omnicell Announces First Quarter 2015 Results 17Omnicell Announces First Quarter 2015 Results 18Omnicell Announces First Quarter 2015 Results 19Omnicell Announces First Quarter 2015 Results 20Omnicell Announces First Quarter 2015 Results 21Omnicell Announces First Quarter 2015 Results 22Omnicell Announces First Quarter 2015 Results 23Omnicell Announces First Quarter 2015 Results 24Omnicell Announces First Quarter 2015 Results 25Omnicell Announces First Quarter 2015 Results 26Omnicell Announces First Quarter 2015 Results 27
... Mont., Feb. 1, 2012 Bacterin International Holdings ... leader in the development of revolutionary bone graft material ... Hayden IR , a 15-year-old, highly recognized, national investor ... relations program and raise its visibility and strengthen its ...
... 1, 2012  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ... Food and Drug Administration (FDA) has notified Arena that ... discuss the lorcaserin New Drug Application (NDA) resubmission will ... and details of the meeting will be published in ...
Cached Medicine Technology:Bacterin Retains Hayden IR to Develop Strategic Investor Relations Program 2Bacterin Retains Hayden IR to Develop Strategic Investor Relations Program 3Bacterin Retains Hayden IR to Develop Strategic Investor Relations Program 4Arena Pharmaceuticals Receives Notice from FDA of Advisory Committee Meeting for Lorcaserin 2Arena Pharmaceuticals Receives Notice from FDA of Advisory Committee Meeting for Lorcaserin 3Arena Pharmaceuticals Receives Notice from FDA of Advisory Committee Meeting for Lorcaserin 4
(Date:5/3/2015)... 2015 Indiana Fiber Network, LLC (IFN), ... Computer Services, Inc (BCS) has selected IFN as a ... “The technology, service, and working relationship with IFN has ... local feel you get with IFN. I like ... makes local decisions and operates as a local community ...
(Date:5/3/2015)... (PRWEB) May 03, 2015 SpineFrontier, a ... from the FDA to produce and market their new ... can be used in outpatient settings and is compatible ... alternate posterior approach has been extensively researched and refined ... approval to use this approach in conjunction with a ...
(Date:5/2/2015)... May 02, 2015 Ticket Down has secured ... for the long awaited event today, Saturday, May 2nd at ... boxing fans will be able to secure tickets for both ... fight that boxing fans have wanted for more than five ... Floyd “Money” Mayweather will step inside the ring to fight ...
(Date:5/2/2015)... New York, NY (PRWEB) May 02, 2015 ... – when a deadly natural disaster strikes anywhere on ... ways to leverage human sympathy and compassion for their ... US-CERT (United States Computer Emergency Readiness Team) issued ... warning users “of potential email scams citing the earthquake ...
(Date:5/2/2015)... 02, 2015 Kare Visits LLC. launched in ... busy caregivers. Kare Visits offers relief for caregivers by ... facilities. According to the Caregiver Action Network, eight ... of 20 hours a week caring for an elderly or ... to hire a nurse, a caregiver is now empowered to ...
Breaking Medicine News(10 mins):Health News:Bank Computer Services, Inc Selects Indiana Fiber Network, LLC as Fiber Transport Provider 2Health News:Bank Computer Services, Inc Selects Indiana Fiber Network, LLC as Fiber Transport Provider 3Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:Chicagoan Seeks to Transform Industry by Launching an Innovative Elderly Care Solution 2
... 3 Health Care Service Corporation (HCSC),which operates the ... Oklahoma and Texas, today announced that its board of ... chief executive officer,effective Nov. 1, 2008., Hemingway Hall, ... since November 2007, will succeed Raymond F. McCaskey, who ...
... emergency physicians access to earn CME ... credit for watching online video procedures, NEW ... leading global provider of information resources for the,scientific and ... the largest membership organization for emergency,physicians, to launch Continuing ...
... Educational resources and special product offers available in store during ... American Diabetes Month ... retail pharmacy, is educating patients about managing and,preventing diabetes during ... during the month on products for patients,with diabetes., Nearly ...
... is available in German . , SARS, ... becoming increasingly frequent. And we still don,t have vaccines for ... classes of viral diseases is the zoonosis, which can be ... of these is caused by the West Nile virus (WNV), ...
... have found that reducing the levels of vascular endothelial growth ... new blood vessel growth, in adult mice causes the death ... that are essential to visual function. This finding, published in ... for the chronic use of promising new anti-VEGF drugs such ...
... Program; Inaugural Partner for ... Fund(R), LONDON, Nov. 3 Susan G. ... organization in the world, is teaming with,Samsung Electronics ... in Europe, in a collaboration unparalleled in the ...
Cached Medicine News:Health News:Hemingway Hall Named CEO of Health Care Service Corporation 2Health News:McGraw-Hill Professional and American College of Emergency Physicians Roll Out CME Functionality On AccessEmergency Medicine 2Health News:McGraw-Hill Professional and American College of Emergency Physicians Roll Out CME Functionality On AccessEmergency Medicine 3Health News:CVS/pharmacy Helps Patients Manage Diabetes Care 2Health News:Therapeutic vaccines 2Health News:Anti-VEGF drugs for retinal diseases could have serious side effects, scientists caution 2Health News:Anti-VEGF drugs for retinal diseases could have serious side effects, scientists caution 3Health News:Samsung and Susan G. Komen for the Cure(R) Launch Historic Breast Cancer Alliance 2Health News:Samsung and Susan G. Komen for the Cure(R) Launch Historic Breast Cancer Alliance 3
... instrument engineered to match the speed of ... system is based on heat transfer by ... tubes or thin walled micorcentrifuge tubes. Heating ... high velocity air results in nearly instantaneous ...
Contains: Card, cabling and instructions to remotely access a RoboCycler® instrument from a PC or Macintosh® computer...
... Biosystems has designed its 60-well, 0.5 mL ... PCR applications (both DNA and RNA). The ... Frame ensure oil-free operation in the 0.5 ... the 0.5 mL GeneAmp PCR System 9700 ...
... Mx3005P instrument and custom filter wheels ... filters. The standard filter set includes: ... ROX/Texas Red (585nm-610nm), Cy5 (635nm-665nm) and ... Mx3005P analysis software, Beacon Designer oligo ...
Medicine Products: